Literature DB >> 18325820

HFE gene mutations in a population of Italian Parkinson's disease patients.

Giorgio Biasiotto1, Stefano Goldwurm, Dario Finazzi, Sara Tunesi, Anna Zecchinelli, Francesca Sironi, Gianni Pezzoli, Paolo Arosio.   

Abstract

An abnormal accumulation and distribution of brain iron are common to different neurodegenerative disorders, including Parkinson's disease (PD), and alteration of genes involved in iron metabolism cause neurodegeneration with brain iron accumulation. HFE participates in the regulation of iron metabolism, its mutations are primary cause of hereditary hemochromatosis and appear to be more frequent in neurodegenerative disorders such as Alzheimer's disease and amyotrophic lateral sclerosis. However, conflicting results were obtained in previous studies aimed to verify if nucleotide variations in HFE gene act as risk modifiers for PD. We used denaturing HPLC for scanning DNA sequence variations in exon 2 and 4 of HFE gene in a cohort of 475 Italian PD patients. We identified the most common H63D, C282Y and S65C, and also other 4 rare mutation types (R66H, R224W, E277K, and T281M). The allele frequency of H63D and C282Y was not statistically different from that of 2 control groups with similar mean age or of a large cohort of the same geographical area. In addition we could not find statistical differences in the clinical phenotypes of patients carrying at least one mutated HFE allele from those with the normal allele. We conclude that in the Italian population, the most common HFE mutations, H63D and C282Y are not associated with the individual risk to develop PD, nor have specific influence on the clinical features of the disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18325820     DOI: 10.1016/j.parkreldis.2007.10.011

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  9 in total

1.  Association study between four polymorphisms in the HFE, TF and TFR genes and Parkinson's disease in southern Italy.

Authors:  Valentina Greco; Elvira Valeria De Marco; Francesca Emanuela Rocca; Ferdinanda Annesi; Donatella Civitelli; Giovanni Provenzano; Patrizia Tarantino; Vittorio Scornaienchi; Franco Pucci; Maria Salsone; Fabiana Novellino; Maurizio Morelli; Sandra Paglionico; Antonio Gambardella; Aldo Quattrone; Grazia Annesi
Journal:  Neurol Sci       Date:  2011-03-08       Impact factor: 3.307

2.  Analysis of nucleotide variations in genes of iron management in patients of Parkinson's disease and other movement disorders.

Authors:  Emanuela Castiglioni; Dario Finazzi; Stefano Goldwurm; Gianni Pezzoli; Gianluca Forni; Domenico Girelli; Federica Maccarinelli; Maura Poli; Maurizio Ferrari; Laura Cremonesi; Paolo Arosio
Journal:  Parkinsons Dis       Date:  2010-10-17

Review 3.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

4.  Levodopa Responsive Parkinsonism in Patients with Hemochromatosis: Case Presentation and Literature Review.

Authors:  Tarun Girotra; Abhimanyu Mahajan; Christos Sidiropoulos
Journal:  Case Rep Neurol Med       Date:  2017-03-23

5.  Genomewide association study for onset age in Parkinson disease.

Authors:  Jeanne C Latourelle; Nathan Pankratz; Alexandra Dumitriu; Jemma B Wilk; Stefano Goldwurm; Gianni Pezzoli; Claudio B Mariani; Anita L DeStefano; Cheryl Halter; James F Gusella; William C Nichols; Richard H Myers; Tatiana Foroud
Journal:  BMC Med Genet       Date:  2009-09-22       Impact factor: 2.103

6.  Common and rare variants in HFE are not associated with Parkinson's disease in Europeans.

Authors:  Prabhjyot Saini; Sara Bandres-Ciga; Jose Luis Alcantud; Clara Ruz; Ronald B Postuma; Ziv Gan-Or
Journal:  Neurobiol Aging       Date:  2021-06-08       Impact factor: 4.673

7.  Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study.

Authors:  Irene Pichler; Fabiola Del Greco M; Martin Gögele; Christina M Lill; Lars Bertram; Chuong B Do; Nicholas Eriksson; Tatiana Foroud; Richard H Myers; Michael Nalls; Margaux F Keller; Beben Benyamin; John B Whitfield; Peter P Pramstaller; Andrew A Hicks; John R Thompson; Cosetta Minelli
Journal:  PLoS Med       Date:  2013-06-04       Impact factor: 11.069

Review 8.  Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration.

Authors:  Scott Ayton; Peng Lei
Journal:  Biomed Res Int       Date:  2014-01-16       Impact factor: 3.411

Review 9.  Parkinson's Disease: The Mitochondria-Iron Link.

Authors:  Yorka Muñoz; Carlos M Carrasco; Joaquín D Campos; Pabla Aguirre; Marco T Núñez
Journal:  Parkinsons Dis       Date:  2016-05-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.